Inspired by the successful television series, the UCL School of Pharmacy has organised this clever and well-attended event where UCL scientists presented their small molecule therapeutics idea to a panel of seasoned pharma experts and investors, in front of a public of scientists and company representatives. We couldn’t resist the temptation to pitch our Virology Research Services, and although VRS is not quite a small molecule, it was clearly exciting enough to win the third prize from the public! Thank you!

More Blog Posts

Recents Posts

Current and Future Antiviral Research

Current and Future Antiviral Research

A virus mutates, an antiviral loses potency, and a new outbreak finds us one step behind. This cycle has defined antiviral medicine for decades. Now, a convergence of broad-spectrum drug design, host-targeted therapies, AI-driven discovery, nanotechnology, and CRISPR...

Find out how we can help

When it comes to viruses, we know our stuff!

Subscribe